Implications for practice
cancer, Cancer
CANCER, BOWEL CANCER, CANCER
The intervention led to higher rates of overscreening in those who were not due screening, mainly through overordering iFOBT tests. With the implementation of the National Cancer Screening Register, it should be possible to reduce this overscreening by determining when someone is due their next iFOBT. This information in the National Cancer Screening Register could also be used to determine when a CRISP risk assessment should be performed. The current intervention aimed to reduce colonoscopies in people at average risk of CRC. Five-year follow-up data will be reported on potential reductions in colonoscopies in average-risk patients and the longer-term cost-effectiveness of the CRISP tool.Risk-stratified screening targets more intensive screening to populations with higher rates of cancer, and, if fully implemented, would reduce screening intensity in those at lower risk.The authors thank all the trial participants and general practices who were involved in this trial. The authors are grateful to the Victorian Department of Health and Services Australia for their support in obtaining Victorian Admittted Episodes Dataset, Medicare Benefits Schedule, and National Bowel Cancer Screening Program data.